Search

01/07/2021 Impact of the COVID-19 pandemic on tuberculosis management in Spain
Aznar, ML, Espinosa-Pereiro, J, Saborit, N, Jove, N, Martinez, FS, Perez-Recio, S, Vitoria, A, Sanjoaquin, I, Gallardo, E, Llenas-Garcia, J, Pomar, V, Garcia, IO, Cacho, J, Freitas, LGD, San Martin, JV, Rodriguez, JFG, Jimenez-Fuentes, MA, De Souza-Galvao, ML, Tortola, T, Zules, R, Molina, I, Sanchez-Montalva, A. Impact of the COVID-19 pandemic on tuberculosis management in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 108DOI:10.1016/j.ijid.2021.04.075. PMID:33930543. IF:12.073(Q1/2D).
19/10/2022 C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Caravaca-Fontan, F, Lucientes, L, Serra, N, Cavero, T, Rodado, R, Ramos, N, Gonzalez, F, Shabaka, A, Cabello, V, Huerta, A, Pampa-Saico, S, Gutierrez, E, Quintana, LF, Lopez-Rubio, ME, Draibe, J, Titos, JA, Fernandez-Juarez, G, De Jorge, EG, Praga, M. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(11)DOI:10.1093/ndt/gfab302. PMID:34677610. IF:6.100(Q1/2D).
24/01/2022 Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
Rodriguez-Temporal, D, Alcaide, F, Marekovic, I, O'Connor, JA, Gorton, R, van Ingen, J, Van den Bossche, A, Hery-Arnaud, G, Beauruelle, C, Orth-Holler, D, Palacios-Gutierrez, JJ, Tudo, G, Bou, G, Ceyssens, PJ, Garrigo, M, Gonzalez-Martin, J, Greub, G, Hrabak, J, Ingebretsen, A, Mediavilla-Gradolph, MC, Oviano, M, Palop, B, Pranada, AB, Quiroga, L, Ruiz-Serrano, MJ, Rodriguez-Sanchez, B. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-05315-7. PMID:35075208. IF:4.600(Q2/4D).
01/01/2022 Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity
Bravo, MS, Berengua, C, Marin, P, Esteban, M, Rodriguez, C, del Cuerpo, M, Miro, E, Cuesta, G, Mosquera, M, Sanchez-Palomino, S, Vila, J, Rabella, N, Marcos, MA. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity. JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1)DOI:10.1128/JCM.01609-21. PMID:34669457. IF:9.400(Q1/2D).